Column Group IV GP, LP
SEC insider (Form 3/4/5 filer). CIK 0001796356. 10% Owner at Eikon Therapeutics, Inc. (EIKN). 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SAN FRANCISCO, CA.
Companies Column Group IV GP, LP has filed insider reports for
- Eikon Therapeutics, Inc. (EIKN): 10% Owner
Column Group IV GP, LP
CIK: 0001796356
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eikon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 3, 2026EIKN
Eikon Therapeutics, Inc.
PurchaseIndirect89.2K shares at avg. $11.56$1.0M - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect1.4M shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect110.9K shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect44.2K shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect47.9K shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect1.3M shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
ConversionIndirect688.3K shares- - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
PurchaseIndirect1.4M shares at avg. $18.00$25.9M - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
PurchaseIndirect49.6K shares at avg. $18.00$892K - Feb 6, 2026EIKN
Eikon Therapeutics, Inc.
PurchaseIndirect630.9K shares at avg. $18.00$11.4M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | EIKN Eikon Therapeutics, Inc. | Purchase | 89,200 | $11.56 | $1,031,045 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 1,403,568 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 110,928 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 44,249 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 47,898 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 1,296,629 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Conversion | 688,283 | - | $0 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Purchase | 1,437,323 | $18.00 | $25,871,814 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Purchase | 49,556 | $18.00 | $892,008 | Indirect |
| Feb 6, 2026 | EIKN Eikon Therapeutics, Inc. | Purchase | 630,881 | $18.00 | $11,355,858 | Indirect |
1-10 of 11 transactions